Abbott India Ltd News
Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
 "Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally")
Nifty resistance stands at 25,000-mark; Bias for Bank Nifty turns positive
F&O cues for Oct 21: Despite Friday's recovery, Nifty options continues to reflect cautious sentiment, with call writing outweighing put writing on Friday, said Dhupesh Dhameja of SAMCO Securities.
 "Nifty resistance stands at 25,000-mark; Bias for Bank Nifty turns positive")
Abbott India recalls Pentids antibiotic batches over packaging issues
Pentids are widely prescribed for treating bacterial infections of the respiratory tract, throat, lungs, nose, skin, and sexually transmitted diseases like syphilis
 "Abbott India recalls Pentids antibiotic batches over packaging issues")
Here's why Abbott India stock price surged 5% on August 8; details here
The uptick in the pharma company's stock price came after it posted a healthy set of numbers in the June quarter of financial year 2025 (Q1FY25).
 "Here's why Abbott India stock price surged 5% on August 8; details here")
Abbott India Q1 results: PAT rises 13% to Rs 328 cr, income at Rs 1,625 cr
Drug firm Abbott India on Wednesday said its net profit increased by 13 per cent year on year to Rs 328 crore for the first quarter ended June 30, 2024. The company reported a net profit of Rs 290 crore in the April-June quarter of last fiscal. Total income rose to Rs 1,625 crore for the period under review as against Rs 1,535 crore in the June quarter of FY24, Abbott India said in a regulatory filing. Shares of the company on Wednesday ended 1.29 per cent up at Rs 28,159.95 apiece on the BSE.
